ALFA Filings
Every announcement, straight from the exchange
Every Supriya Lifescience results update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Supriya Lifescience's Q2 FY27 revenue rose 3.2%, but EBITDA and PAT fell sharply. Ambernath ramp-up costs and LATAM regulatory shifts hurt margins.
Supriya Lifescience announced financial highlights for Q1 FY27, reporting revenue of Rs. 189.75 crore and profit after tax of Rs. 24.04 crore for the quarter.
Supriya Lifescience reported FY26 revenue of ₹827.87 Crore, up 18.9% YoY. Strong Q4 performance and capacity expansion signal robust growth across key therapeutic segments.